This inventor holds 8 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignee: Vanda Pharmaceuticals Inc.. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Washington, DC (US) (2022)
- Cleveland, OH (US) (2022 - 2023)
Company Filing History:
Years Active: 2022-2026
Title: **Sandra Smieszek: Pioneering Innovations in Psychopharmacology**
Introduction
Sandra Smieszek is a renowned inventor based in Cleveland, OH, whose groundbreaking work in the field of psychopharmacology has garnered her a total of five patents. Her innovative approach to enhancing antipsychotic treatments reflects a deep commitment to improving the lives of individuals suffering from mental health disorders.
Latest Patents
Among her most notable inventions are two significant patents. The first patent, titled "Genetic markers for enhancing efficacy of antipsychotic treatment with iloperidone," introduces a method for selecting patients who may experience enhanced treatment efficacy based on their genotypes at specific single nucleotide polymorphism (SNP) loci. This tailored approach allows for more effective treatment plans rooted in individual genetic information.
Her second patent is an innovative "Method of treatment of schizophrenia," which focuses on advancements in the identification of individuals likely to benefit from iloperidone or its metabolites. By analyzing genotypes at the PPEF2 locus, her invention aims to refine and enhance the treatment of psychotic symptoms, providing a targeted strategy for patient care.
Career Highlights
Sandra Smieszek has made significant contributions to the pharmaceutical industry, particularly during her tenure at Vanda Pharmaceuticals Inc. Her research and inventions have propelled forward the understanding of genetic influences on medication responses, leading to optimized treatment protocols for psychiatric disorders.
Collaborations
Throughout her career, Sandra has collaborated with esteemed colleagues such as Mihael Hristos Polymeropoulos and Changfu Xiao. These collaborations have enriched her research endeavors and have been instrumental in pushing the boundaries of current knowledge in the field.
Conclusion
In conclusion, Sandra Smieszek’s innovative contributions to the field of psychopharmacology exemplify the potential of personalized medicine in treating mental health conditions. Her patents not only reflect her expertise as an inventor but also her dedication to improving patient outcomes through genetic understanding. As her work continues to influence the industry, Sandra Smieszek stands out as a leader in the advancement of psychotropic treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile